63rd Annual Meeting of the American Society of Tropical Medicine and Hygiene

November 2, 2014 - 8:00am - November 6, 2014 - 8:00pm
Sheraton New Orleans

Join MSH in New Orleans at this year's ASTMH meeting. 


Assessment of Supply Chain Management (SCM) Systems  for Neglected Tropical Disease (NTD) Drugs in Cameroon, Mali, Tanzania, and Uganda

Tuesday, November 4, 2014 | 12:00PM-1:45PM
Poster Session B Presentations and Light Lunch

The rapid expansion of NTD control activities has not been without pharmaceutical and health system challenges. The purpose of the four country assessment of the pharmaceutical and supply chain management of NTD control programs was to identify the gaps and make recommendations for strengthening the system. Qualitative and quantitative information concerning NTD medicine availability and management were collected using structured assessment tools, interviews of healthcare workers, and direct observations at sample sites at national, regional, districts and peripheral facilities. The questionnaires focused on availability of treatment guidelines, procurement, distribution, and stock management practices, as well as the adverse drug reaction reporting, disposal of expired products, reverse logistics challenges following MDA and integration with relevant national services and structures. Along the supply chain several NTD medicines were not documented in certain depots due to poor stock management practices. Donated NTD medicines sourced from the manufacturers makes quality issues less of a concern. However, there are concerns on the downstream quality of NTD medicines as the medicines come in loose pills and are distributed from containers. The outdoor nature of the MDA’s increases the chances of exposure of the medicines to humidity, heat, dust, and other unhygienic situations. NTD programs had difficulty getting information on the actual amounts of medicines distributed by the national medical store to the districts. Likewise, information on persons treated, doses dispensed and balance of stock medicine from MDA sites and districts is not always submitted on time and the quality of data not reliable, making planning and forecasting difficult. The assessment identified both strengths and weaknesses in the different aspects of NTD pharmaceutical management. Following the assessment, two post-assessment workshops were conducted for the purpose of disseminating the assessment report and to reach consensus with key stakeholders and partners on the way forward.


Current Status and Progress of Integrated Community Case Management (iCCM) in Africa: Latest Evidence, Lessons Learned and Best Practice for Implementation


Wednesday, November 5, 2014 | 4:00PM-5:45PM
Sheraton Grand Ballroom B (Fifth Floor)

Integrated community case management (iCCM) increases access to treatment to those beyond the reach of health facilities and has the potential to more equitably address the three largest causes of child mortality in sub-Saharan Africa. Since 2000, the use of iCCM to deliver pneumonia, malaria and diarrhea treatments to children under five through community health workers (CHWs) has dramatically increased. The iCCM/CHW platform is increasingly being used to manage newborn infections and child malnutrition. Previous iCCM symposia at ASTMH Annual Meetings in 2012 and 2013 focused on some of the early program experiences and operational research activities in specific countries. In recent years, there has been tremendous scale-up of iCCM in many countries, and today more than 30 countries in Africa have adopted iCCM as a major child survival strategy. A large body of evidence has now been accumulated on the strengths and limitations of the approach, as well as the costs and cost-effectiveness. This iCCM symposium will present the latest evidence, best practice and lessons learned from the implementation experiences across multiple countries. Discussion will focus on how to foster sustainable long-term support for iCCM and CHW service delivery to strengthen access to treatment and comprehensive management of the sick child at the community level, including use of mobile technologies and other innovations to support CHWs in their work.